Akouos Raises Over $200M in IPO
- Posted by ISPE Boston
- On July 9, 2020
Boston-based biotech Akouos has raised gross proceeds of $244 million in its June stock market debut. Akouos is a precision genetic medicine company dedicated to developing gene therapies for people worldwide who live with disabling hearing loss. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery […]
Read More